Ignite Creation Date:
2024-05-05 @ 11:51 AM
Last Modification Date:
2024-10-26 @ 9:15 AM
Study NCT ID:
NCT00154492
Status:
COMPLETED
Last Update Posted:
2017-01-13
First Post:
2005-09-09
Brief Title:
Use of NovoSeven in Active Variceal Bleeding
Sponsor:
Novo Nordisk AS
Organization:
Novo Nordisk AS
Study Overview
Official Title:
Effectiveness and Safety of Use of NovoSeven in the Treatment of Active Variceal Bleeding in Patients With Advanced Cirrhosis
Status:
COMPLETED
Status Verified Date:
2017-01
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
This trial is conducted in Asia and Europe The trial is planned to investigate the effectiveness and safety of NovoSeven in patients with advanced cirrhosis and active variceal bleeding
Detailed Description:
None
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None